Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Chen J, Su C.

Cancer Lett. 2020 Jan 8. pii: S0304-3835(19)30648-2. doi: 10.1016/j.canlet.2019.12.034. [Epub ahead of print] No abstract available.

PMID:
31926781
2.

Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma.

Yin H, Que R, Liu C, Ji W, Sun B, Lin X, Zhang Q, Zhao X, Peng Z, Zhang X, Qian H, Chen L, Yao Y, Su C.

Cancer Lett. 2018 Jul 1;425:54-64. doi: 10.1016/j.canlet.2018.03.044. Epub 2018 Mar 30.

PMID:
29608986
3.

[Analysis of a consanguineous pedigree affected with hereditary coagulation factor XII deficiency caused by homozygous Gly341Arg mutation].

Yang L, Jin S, Ji W, Cheng X, Li X, Jin Y, Wang M.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Feb 10;35(1):69-73. doi: 10.3760/cma.j.issn.1003-9406.2018.01.015. Chinese.

PMID:
29419864
4.

A rapid quantitative analysis of bile acids, lysophosphatidylcholines and polyunsaturated fatty acids in biofluids based on ultraperformance liquid chromatography coupled with triple quadrupole tandem massspectrometry.

Peng Z, Zhang Q, Mao Z, Wang J, Liu C, Lin X, Li X, Ji W, Fan J, Wang M, Su C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Nov 15;1068-1069:343-351. doi: 10.1016/j.jchromb.2017.10.066. Epub 2017 Nov 6.

PMID:
29129603
5.

Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway.

Li C, Zhu M, Lou X, Liu C, Chen H, Lin X, Ji W, Li Z, Su C.

Oncotarget. 2017 May 20;8(42):71933-71945. doi: 10.18632/oncotarget.18035. eCollection 2017 Sep 22.

6.
7.

Targeting MicroRNAs in Cancer Gene Therapy.

Ji W, Sun B, Su C.

Genes (Basel). 2017 Jan 9;8(1). pii: E21. doi: 10.3390/genes8010021. Review.

8.

Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma.

Lin X, Peng Z, Fu X, Liu C, Xu Y, Ji W, Fan J, Chen L, Fang L, Huang Y, Su C.

Oncotarget. 2016 Nov 29;7(48):79761-79773. doi: 10.18632/oncotarget.12962.

9.

Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.

Yi B, Qiu Y, Ji W, Wei M, Liu C, Peng Z, Zhang Y, Quan Z, Tang Z, Su C.

Cancer Lett. 2016 Oct 28;381(2):349-58. doi: 10.1016/j.canlet.2016.08.002. Epub 2016 Aug 5.

PMID:
27502167
10.

An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma.

Li X, Su Y, Sun B, Ji W, Peng Z, Xu Y, Wu M, Su C.

Mol Cancer Ther. 2016 Jul;15(7):1436-51. doi: 10.1158/1535-7163.MCT-16-0096. Epub 2016 May 18.

11.

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.

Su Y, Sun B, Lin X, Zhao X, Ji W, He M, Qian H, Song X, Yang J, Wang J, Chen J.

Oncotarget. 2016 Aug 2;7(31):49143-49155. doi: 10.18632/oncotarget.9237.

12.

Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.

Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y, Gao Q, Su C.

Cancer Lett. 2015 Nov 1;368(1):126-134. doi: 10.1016/j.canlet.2015.07.035. Epub 2015 Aug 7.

PMID:
26259512
13.

A Novel Matrine Derivative WM130 Inhibits Activation of Hepatic Stellate Cells and Attenuates Dimethylnitrosamine-Induced Liver Fibrosis in Rats.

Xu Y, Peng Z, Ji W, Li X, Lin X, Qian L, Li X, Chai X, Wu Q, Gao Q, Su C.

Biomed Res Int. 2015;2015:203978. doi: 10.1155/2015/203978. Epub 2015 Jun 18.

14.

Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.

Hu H, Qiu Y, Guo M, Huang Y, Fang L, Peng Z, Ji W, Xu Y, Shen S, Yan Y, Huang X, Zheng J, Su C.

Oncotarget. 2015 Jan 20;6(2):1079-89.

15.

Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma.

Li Z, Li X, Li C, Su Y, Fang W, Zhong C, Ji W, Zhang Q, Su C.

Cancer Lett. 2014 Nov 1;354(1):77-86. doi: 10.1016/j.canlet.2014.07.049. Epub 2014 Aug 12.

PMID:
25128069
16.

Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model.

Xu G, Ji W, Su Y, Xu Y, Yan Y, Shen S, Li X, Sun B, Qian H, Chen L, Fu X, Wu M, Su C.

Oncotarget. 2014 Jul 15;5(13):5029-39.

17.

Anti-tumor activities of matrine and oxymatrine: literature review.

Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q, Su C.

Tumour Biol. 2014 Jun;35(6):5111-9. doi: 10.1007/s13277-014-1680-z. Epub 2014 Feb 14. Review.

PMID:
24526416
18.

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.

Wang W, Ji W, Hu H, Ma J, Li X, Mei W, Xu Y, Hu H, Yan Y, Song Q, Li Z, Su C.

Oncotarget. 2014 Jan 15;5(1):150-60.

19.

Small molecule with big role: MicroRNAs in cancer metastatic microenvironments.

Su Y, Li X, Ji W, Sun B, Xu C, Li Z, Qian G, Su C.

Cancer Lett. 2014 Mar 28;344(2):147-56. doi: 10.1016/j.canlet.2013.10.024. Epub 2013 Oct 30. Review.

PMID:
24184826
20.

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J.

Cancer Lett. 2013 Sep 1;337(2):226-36. doi: 10.1016/j.canlet.2013.05.007. Epub 2013 May 14. Erratum in: Cancer Lett. 2020 Jan 8;:.

PMID:
23684551

Supplemental Content

Loading ...
Support Center